Annovis Bio Inc.
Clinical trials sponsored by Annovis Bio Inc., explained in plain language.
-
3-Year safety check for promising Parkinson's drug
Disease control Recruiting nowThis study aims to check the long-term safety of buntanetap, an experimental drug for Parkinson's disease, over three years. It will include 500 participants, some who have tried buntanetap before and others who use deep brain stimulation devices. The main goal is to monitor for …
Phase: PHASE2, PHASE3 • Sponsor: Annovis Bio Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Major Alzheimer's trial tests drug to slow memory loss
Disease control Recruiting nowThis large Phase 3 trial is testing whether a daily pill called buntanetap can help people with early Alzheimer's disease. Researchers will enroll 760 adults aged 55-85 and randomly assign them to take either the real drug or a placebo for 18 months. The study will measure whethe…
Phase: PHASE3 • Sponsor: Annovis Bio Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC